ACS Journal Cancer

The Psychosocial Oncology section of CANCER features high-quality research with broad clinical relevance. Learn what we’re seeking from Section Editor Jennifer Knight, MD, MS. Full video: youtu.be/p1e26eIl754 Submit your work: acsjournals.onlinelibrary.wiley.com/journal/109701… @OncoAlert #APOS2026

New in-depth review discusses the principles of neoadjuvant #immunotherapy for cutaneous #melanoma and invasive cutaneous squamous cell carcinoma. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert CC: @diwakardavar @MelanomaReAlli @CureMelanoma

Attending #APOS2026? Consider CANCER as the home for your next #PsychosocialOncology research article. Hear from our Section Editor, Jennifer Knight, MD, MS, on priorities for submissions. Why submit: acsjournals.onlinelibrary.wiley.com/journal/109701… Full video: youtu.be/p1e26eIl754 @OncoAlert

As the field of #PsychosocialOncology continues moving forward, CANCER is committed to publishing high-quality research that connects psychosocial factors with clinical cancer outcomes. Hear from Dr. Jennifer Knight on the field’s direction: youtu.be/p1e26eIl754 @OncoAlert

New #OpenAccess work led by Dr Joanna Arch of @CUCancerCenter 🔓 The Valued Living intervention, implemented by social workers in community oncology clinics, increased ACP & wellbeing among depressed & anxious adults with advanced cancer. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

New study assesses the eligibility criteria in randomized controlled trials in metastatic non–small cell lung cancer: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #NSCLC #LCSM #ClinicalTrials

Attending #APOS2026? Consider @JournalCancer as the home for your next #PsychosocialOncology research article 📗 Learn more about submitting to CANCER: ow.ly/F9uE50YvCxw

New #OpenAccess phase 2 study results: The addition of durvalumab to chemoRT was well tolerated & showed encouraging efficacy, supporting further investigation in patients with LS-SCLC eligible for radical chemoRT. 🔗: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert CC: @SclcSMASHERS

The @AmericanCancer Journals are now fully represented on Instagram! If you're on Instagram, be sure to follow ACSJournals to stay up to date with our portfolio. 📚

New editorial by Damon R. Reed MD & Emily K. Slotkin MD of @MSKCancerCenter comments on recent consensus recommendations in the management of jaw (gnathic) osteosarcoma. Editorial: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Related article: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

#OpenAccess from @UTMDAnderson researchers 🔓 High dietary fiber is associated w/ improved outcomes in patients w/ melanoma & sarcoma treated w/ immunotherapy regardless of gut microbiome dysbiosis & social vulnerability acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert CC: @diwakardavar

This new study identified a specific triple classification staining pattern of p16INK4a expression in #GastricCancer, and demonstrated that p16INK4a overexpression was associated with poor clinical outcomes and evasive immune contexture. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

New & available #OpenAccess | A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950) acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @teekayowo CC: @PatelOncology #HNCSM

"Bønløkke et al have highlighted the potential for next-generation sequencing-based, tumor tissue-agnostic detection of circulating cell-free-HPV DNA for cervical cancer recurrence monitoring." New editorial by Dr Kathy Han of @pmcancercentre: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

Congratulations to Kenneth K. Tanabe, MD, long-time Hepatobiliary Disease Section Editor for Cancer, who took office as President of @SocSurgOnc earlier this month at #SSO2026. 🎥 Watch a recent video of Dr. Tanabe discussing developments in #LiverCancer. @MassGeneralNews

New study from Dr Elizabeth Kantor et al describes modifications to #BreastCancer chemotherapy from intended in the real-world setting. 1 in 3 women did not receive chemotherapy as intended, varying by regimen administered. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @MSKCancerCenter

New today! A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic #PancreaticCancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @virtahealth @OncoAlert #pancan

New work from @DDoroshow et al reports on the Olaparib Combinations trial in its entirety, including all completed arms involving olaparib monotherapy and the combination of olaparib with either ceralasertib or capivasertib. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @PatelOncology

New review available #OpenAccess | Review of patient-reported outcomes in EMPOWER-Lung 1 in patients with advanced non-small cell lung cancer treated with cemiplimab versus chemotherapy acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #ClinicalTrials #LCSM #NSCLC

New Phase 3 #ClinicalTrial 📊 Results suggest the addition of trastuzumab to chemoradiation for localized HER2+ esophageal adenocarcinoma did not improve patient-reported outcomes. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @NRGonc CC: @CathyEngMD